Paper Calls Oregon Race for the Democrat
The Democrats fell short in their quest for 60 U.S. Senate seats, but the race isn't quite over. After a fierce battle in the politically fascinating state of Oregon, Democratic usurper Jeff Merkley has been projected by The Oregonian to defeat Sen. Gordon Smith. That leaves Minnesota and Georgia. Update
The Democrats fell short in their quest for 60 U.S. Senate seats, but the race isn’t quite over. After a fierce battle in the politically fascinating state of Oregon, Democratic usurper Jeff Merkley has been projected by The Oregonian to defeat Sen. Gordon Smith. That leaves Minnesota and Georgia.
Sen. Norm Coleman’s razor-thin margin over Al Franken up north triggered an automatic recount, while Georgia’s Saxby Chambliss will probably have to face rival Jim Martin in a runoff.
Update: Smith has conceded.
The Oregonian:
Democrat Jeff Merkley has leapt from Oregon’s statehouse to the U.S. Senate, ousting two-term Republican Gordon Smith after an expensive, high-stakes contest that will help shift the balance of power in Washington.
The Oregonian projects that Merkley will squeak by Smith by the time all votes are counted.
Merkley, a five-term state lawmaker and former Habitat for Humanity director, took advantage of a surge of Democratic support to win the bitterly fought battle with Smith, a Pendleton frozen food magnate who also rose from the Oregon Legislature.
WAIT BEFORE YOU GO...This year, the ground feels uncertain — facts are buried and those in power are working to keep them hidden. Now more than ever, independent journalism must go beneath the surface.
At Truthdig, we don’t just report what's happening — we investigate how and why. We follow the threads others leave behind and uncover the forces shaping our future.
Your tax-deductible donation fuels journalism that asks harder questions and digs where others won’t.
Don’t settle for surface-level coverage.
Unearth what matters. Help dig deeper.
Donate now.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.